- Home
- SILC vs ZTEK Comparison
SILC vs ZTEK Comparison
Compare SILC & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILC
- ZTEK
- Stock Information
- Founded
- SILC 1987
- ZTEK 2008
- Country
- SILC Israel
- ZTEK Canada
- Employees
- SILC N/A
- ZTEK N/A
- Industry
- SILC Computer Manufacturing
- ZTEK Major Chemicals
- Sector
- SILC Technology
- ZTEK Industrials
- Exchange
- SILC Nasdaq
- ZTEK Nasdaq
- Market Cap
- SILC 86.2M
- ZTEK 81.7M
- IPO Year
- SILC 1994
- ZTEK N/A
- Fundamental
- Price
- SILC $17.50
- ZTEK $0.81
- Analyst Decision
- SILC Hold
- ZTEK
- Analyst Count
- SILC 1
- ZTEK 0
- Target Price
- SILC N/A
- ZTEK N/A
- AVG Volume (30 Days)
- SILC 22.4K
- ZTEK 108.6K
- Earning Date
- SILC 10-30-2025
- ZTEK 11-13-2025
- Dividend Yield
- SILC N/A
- ZTEK N/A
- EPS Growth
- SILC N/A
- ZTEK N/A
- EPS
- SILC N/A
- ZTEK N/A
- Revenue
- SILC $58,651,000.00
- ZTEK $678,078.00
- Revenue This Year
- SILC $6.53
- ZTEK N/A
- Revenue Next Year
- SILC $14.10
- ZTEK N/A
- P/E Ratio
- SILC N/A
- ZTEK N/A
- Revenue Growth
- SILC N/A
- ZTEK 2519.47
- 52 Week Low
- SILC $12.29
- ZTEK $0.50
- 52 Week High
- SILC $19.37
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- SILC 54.17
- ZTEK 47.69
- Support Level
- SILC $17.02
- ZTEK $0.76
- Resistance Level
- SILC $18.85
- ZTEK $0.98
- Average True Range (ATR)
- SILC 0.75
- ZTEK 0.08
- MACD
- SILC -0.06
- ZTEK -0.00
- Stochastic Oscillator
- SILC 30.13
- ZTEK 29.37
About SILC Silicom Ltd
Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, FPGA-Based Cards, x86 Open Appliances, Bypass Switches, and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.